Department of Glaucoma, PBMA's H.V. Desai Eye Hospital, Pune, Maharashtra, India.
Indian J Ophthalmol. 2020 Nov;68(11):2435-2438. doi: 10.4103/ijo.IJO_2117_19.
: To assess the impact of primary glaucoma of varying severity and duration on psychosocial functioning and quality of life of patients.
A cross-sectional observational study was carried on 200 patients attending the glaucoma clinic of a tertiary care hospital in western India. After obtaining approval from the institutional ethics committee, written informed consent was taken. All patients underwent a thorough ophthalmic examination. Those with primary glaucoma were classified as per Hodapp-Parrish-Anderson criteria and asked to respond to the National Eye Institute Visual Function Questionnaire (NEIVFQ)-25 questionnaire. Responses were analyzed statistically.
: Overall mean NEIVFQ 25 composite score was 74.4 ± 18.6. Mean scores were 87.0 (SD 7.2) for mild, 75.9 (SD 8.1) for moderate, and 47.0 (SD 13.7) for severe glaucoma groups. Lower scores were associated with males. Driving (62.2, SD 34.6) and ocular pain (63.5, SD 18.7) were maximally affected while color vision (90.1, SD 18.7) and social health (86.7, SD 20.1) were least affected. The duration of treatment had no effect on mean composite scores with impaired scores seen even in newly diagnosed cases. Age of the patient negatively correlated with NEIVFQ 25 composite score.
: With disease progression, the psychosocial functioning of the patients is negatively affected. This effect is irrespective of treatment duration and newly diagnosed cases can have impaired Quality of life scores. Quantification of psychosocial status along with education and counseling for all patients may play a definitive role in customizing treatment and providing patients with a better quality of Life.
评估不同严重程度和持续时间的原发性青光眼对患者社会心理功能和生活质量的影响。
在印度西部一家三级保健医院的青光眼诊所进行了一项横断面观察性研究。在获得机构伦理委员会的批准后，获得了书面知情同意。所有患者均接受了全面的眼科检查。根据 Hodapp-Parrish-Anderson 标准对原发性青光眼患者进行分类，并要求他们回答国家眼科研究所视觉功能问卷（NEIVFQ）-25 问卷。对回答进行了统计分析。
总体平均 NEIVFQ 25 综合评分 74.4 ± 18.6。轻度组平均评分为 87.0（SD 7.2），中度组为 75.9（SD 8.1），重度组为 47.0（SD 13.7）。较低的分数与男性有关。驾驶（62.2，SD 34.6）和眼部疼痛（63.5，SD 18.7）受影响最大，而色觉（90.1，SD 18.7）和社会健康（86.7，SD 20.1）受影响最小。治疗持续时间对平均综合评分没有影响，即使在新诊断的病例中也可见受损评分。患者年龄与 NEIVFQ 25 综合评分呈负相关。
随着疾病的进展，患者的社会心理功能受到负面影响。这种影响与治疗持续时间无关，新诊断的病例可能生活质量评分受损。对所有患者进行社会心理状况的量化以及教育和咨询可能在定制治疗和为患者提供更好的生活质量方面发挥决定性作用。
